Shoufeng Li, Ph.D.
CEO
Dr. Li is a Scientist and Founder of the company. With 20 years of global pharmaceutical industry experience, he is responsible for the overall strategy, direction, and growth of the business.
Before founding Aucta, Dr. Li held management roles at Novartis Pharmaceuticals and Eon Labs (Sandoz).
Dr. Li holds a Ph.D. in Pharmaceutics and an M.S. in Statistics.
Brian Zorn, PharmD
Chief Commercial Officer
With over 26 years of pharmaceutical industry experience, including new product planning, marketing, medical communications and sales, and extensive experience in providing market/product assessments, Mr. Zorn is responsible for the commercial direction of the company.
Mr. Zorn played a key role in the launch and marketing of leading brands, including Omnicef®, Neurontin®, Lyrica® and Diovan®.
Mr. Zorn holds a Doctor of Pharmacy.
Qiaolin Ren, Ph.D.
VP, R&D and Manufacture
With over 15 years of pharmaceutical industry experience, Dr. Ren is responsible for portfolio and pipeline development and management. He has extensive experience in formulation design, process development, technical transfers and manufacturing, and he previously held roles at Novartis, Sandoz, Fougera and Amylin. Dr. Ren holds a Ph.D. in Industrial Pharmacy.
Lixin Gong,
VP, Analytical Development
With 18 years of pharmaceutical industry experience, Ms. Gong is responsible for analytical development, quality management, and regulatory affairs. She has in-depth knowledge and experience of analytical method development and validation and a solid understanding of quality systems and GMP/ GLP/FDA/ICH and DEA regulations. Prior to joining Aucta, she held roles of increasing responsibility with West-Ward, Alpharma, and BMS. Ms. Gong holds a B.S. in Organic Chemistry and an M.S. in Analytical Chemistry.
Weifeng Ji
Director, Analytical Development
With 30 years of pharmaceutical and biotech industry experience, Mr. Ji is responsible for analytical development and quality management. He has in-depth knowledge and experience of analytical method development and validation, product development of CMC lifecycle management and a solid understanding of quality systems and GMP/ GLP/FDA/EMEA/ICH and DEA regulations. He has successfully brought new molecular from pre-clinical through phase I, II and III to commercial lunch in US and EU markets. Prior to joining Aucta, he held roles of increasing responsibility with Johnson and Johnson, Ivax, Boehringer-Ingelheim, Sandoz, Exelixis, and Relypsa. Mr.
Ji holds an M.S. in Chemistry and an M.S. in Information management in information system.
Nithila Duraisamy
Associate Director, Regulatory Affairs
With over 17 years of various industry experience, including regulatory affairs, project management, strategic planning, and operations, Ms. Duraisamy is responsible for Regulatory Affairs operations and strategic planning of Aucta.
She was a core team member for setting up multiple emerging new companies in the past. Previously she held roles in Par Pharmaceuticals (An ENDO, International Company), Apogee Pharma & Sun Network.
Ms. Duraisamy holds B.S. in Microbiology & M.S. in Business Administration.Pedro Bento
Sr. Director, Quality Assurance
Pedro Bento serves as the Senior Director, Global Quality Assurance. He leads Aucta’s Quality Management Systems and has the mission to ensure the organization complies with all applicable Quality regulations.
Pedro is passioned about Quality, being an inclusive leader, supporting mentorship, and embracing diversity and communication in the workplace.
Mr. Bento earned his bachelor’s degree in Biology from Kean University, and a MSc. in Biology from the University of Nebraska.